(Q35605735)

9 August 2017

title

Furthering the prostate cancer screening debate (prostate cancer specific mortality and associated risks). (English)

1 reference

prostate cancer screening

9 August 2017

main subject

1 reference

1 reference

G Michael Allan

1

1 reference

9 August 2017

Michael P Chetner

2

1 reference

9 August 2017

Bryan J Donnelly

3

1 reference

9 August 2017

Neil A Hagen

4

1 reference

9 August 2017

David Ross

5

1 reference

9 August 2017

J Dean Ruether

6

1 reference

9 August 2017

Peter Venner

7

1 reference

9 August 2017

language of work or name

1 reference

1 December 2011

1 reference

Canadian Urological Association journal

9 August 2017

published in

1 reference

9 August 2017

volume

5

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

416-421

1 reference

Screening for prostate cancer: an updated Cochrane systematic review

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Comorbidity and mortality results from a randomized prostate cancer screening trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Screening for breast cancer with mammography

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Cumulative incidence of false-positive results in repeated, multimodal cancer screening

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Screening and prostate-cancer mortality in a randomized European study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Mortality results from a randomized prostate-cancer screening trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

15-year followup of a population based prostate cancer screening study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Uncertainty in heterogeneity estimates in meta-analyses

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Clinical consequences of screening for prostate cancer: 15 years follow-up of a randomised controlled trial in Sweden

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Repeated screening for carcinoma of the prostate by digital rectal examination in a randomly selected population

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

False-positive screening results in the Finnish prostate cancer screening trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

ACP Journal Club. Annual screening for prostate cancer did not reduce mortality from prostate cancer.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

Determining the sample size in a clinical trial.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

État des lieux et facteurs de participation à l’étude européenne ERSPC de dépistage randomisé du cancer de la prostate par dosage sérique de l’antigène prostatique spécifique : départements français du Tarn et de l’Hérault

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235209

The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial

15 November 2018

1 reference

12 December 2020

ACP Journal Club. Population-based screening using prostate-specific antigen testing reduced prostate cancer mortality

1 reference

12 December 2020

Dihydrotestosterone levels and survival in screening-detected prostate cancer: a 15-yr follow-up study

1 reference

12 December 2020

ACP Journal Club. Periodic screening with prostate-specific antigen testing reduced mortality from prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.5489/CUAJ.11063

1 reference

9 August 2017

1 reference

9 August 2017

1 reference